ergonovine has been researched along with thromboxane a2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawaguchi, H; Takahashi, K; Yasuda, H | 1 |
| Sugimoto, T; Uchida, Y | 1 |
| Takahashi, K | 1 |
| Kamada, T; Kodama, K; Kuzuya, T; Nanto, S; Ohmori, M; Tada, M | 1 |
| Khomaziuk, AI | 1 |
| Angus, JA; Cocks, TM; Kemp, BK; Pruneau, D | 1 |
| Auch-Schwelk, W; Fleck, E; Gräfe, M; Hetzer, R; Krackhardt, F; Paetsch, I | 1 |
1 review(s) available for ergonovine and thromboxane a2
| Article | Year |
|---|---|
[Coronary artery spasm (review of the literature)].
Topics: Angina Pectoris, Variant; Animals; Cardiac Catheterization; Coronary Vasospasm; Dogs; Epoprostenol; Ergonovine; Humans; Myocardial Infarction; Nitroglycerin; Platelet Aggregation; Receptors, Adrenergic, alpha; Thromboxane A2 | 1983 |
6 other study(ies) available for ergonovine and thromboxane a2
| Article | Year |
|---|---|
The hypertensive response to vasopressor agents stimulates the release of thromboxane A2 in hypercholesterolaemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Epoprostenol; Ergonovine; Hypercholesterolemia; Nitroglycerin; Norepinephrine; Rabbits; Thromboxane A2; Thromboxane B2; Verapamil | 1989 |
Decreasing potassium conductance: a possible mechanism of supersensitivity and hyperreactivity of coronary artery to prostaglandins, thromboxane A2, and ergonovine.
Topics: Animals; Coronary Vasospasm; Coronary Vessels; Dogs; Ergonovine; In Vitro Techniques; Potassium; Prostaglandins; Thromboxane A2 | 1985 |
[The release of thromboxane A2 and prostacyclin due to vasoactive agents in hypercholesterolemic rabbits].
Topics: Angiotensin II; Animals; Blood Pressure; Epoprostenol; Ergonovine; Hypercholesterolemia; Nitroglycerin; Norepinephrine; Rabbits; Thromboxane A2; Verapamil | 1986 |
Thromboxane A2 as an enhancing factor of coronary vasospasticity in variant angina.
Topics: Adult; Aged; Angina Pectoris, Variant; Coronary Circulation; Coronary Vasospasm; Ergonovine; Female; Humans; Male; Methacrylates; Middle Aged; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Coronary Vessels; Drug Synergism; Ergonovine; Humans; In Vitro Techniques; Isometric Contraction; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents | 1993 |
Modulation of contractions to ergonovine and methylergonovine by nitric oxide and thromboxane A2 in the human coronary artery.
Topics: Adult; Child; Coronary Vessels; Drug Interactions; Ergonovine; Female; Humans; Male; Methylergonovine; Middle Aged; Muscle, Smooth, Vascular; Nitric Oxide; Oxytocics; Serotonin Antagonists; Serotonin Receptor Agonists; Thromboxane A2; Vasoconstriction | 2000 |